Hydroxocobalamin in cyanide poisoning

Clinical Toxicology

Volumn 50, Issue 10, 2012, Pages 875-885

  Thompson, John P ^a   Marrs, Timothy C ^b,c  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Edentox Associates   (United Kingdom)

^c West Midlands Poisons Unit   (United Kingdom)

Author keywords

Cyanide; Fire; Hydrogen cyanide; Hydroxocobalamin; Treatment

Indexed keywords

AMYGDALIN; CYANIDE; HYDROXOCOBALAMIN; NITROPRUSSIDE SODIUM;

ADVERSE OUTCOME; AMYGDALIN POISONING; CYANIDE POISONING; DRUG EFFICACY; DRUG ELIMINATION; DYSPNEA; EXPERIMENTAL MODEL; FACE EDEMA; HUMAN; INTOXICATION; LUNG BURN; NONHUMAN; REVIEW; URTICARIA;

ANIMALS; ANTIDOTES; CYANIDES; DOGS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROXOCOBALAMIN; INHALATION EXPOSURE; MALE; POISONING; PUBMED; RATS; SMOKE; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 84871911548     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2012.742197     Document Type: Review

References (83)

1. Randaccio L, Geremia S, Demitri N, Wuerges J. Vitamin B 12. unique metalorganic compounds and the most complex vitamins. Molecules 2010; 15: 3228-3259.
2. Léonard A, Lauwerys R. Mutagenicity, carcinogenicity and teratogenicity of cobalt metal and cobalt compounds. Mutat Res 1990; 239: 17-27.
3. Lauwerys R, Lison D. Health risks associated with cobalt exposure - an overview. Sci Total Environ 1994; 150: 1-6.
4. Catalani S, Rizzetti MC, Padovani A, Apostoli P. Neurotoxicity of cobalt. Hum Exp Toxicol 2012; 31: 421-437.
5. Paulet G. L 'Intoxication Cyanhydrique et son Traitement. P aris: Masson SA, 1960.
6. Schiff M, Benoist J-F, Tilea B, Royer N, Giraudier S, Ogier de Baulny H. Isolated remethylation disorders: do our treatments benefit patients? J Inherit Metab Dis 2011; 34: 137-145.
7. European Medicines Agency A. Summary of the European public assessment report (EPAR). Cyanokit. [Online] 2012. Available at: http://www.ema.europa.eu/ ema/index.jsp?curl-pages/medicines/human/medicines/000806/human-med-000731.jsp & mid-WC0b01 ac058001d124. Accessed on 3 Jul 2012.
8. Astier A, Baud FJ. Simultaneous determination of hydroxocobalamin and its cyanide complex cyanocobalamin in human plasma by highperformance liquid chromatography. Application to pharmacokinetic studies after high-dose hydroxocobalamin as an antidote for severe cyanide poisoning. J Chromatogr B Biomed Appl 1995; 667: 129-135.
9. Houeto P, Buneaux F, Galliot-Guilley M, Baud FJ, Levillain P. Determination of hydroxocobalamin and cyanocobalamin by derivative spectrophotometry in cyanide poisoning. J Anal Toxicol 1994; 18: 154-158.
10. de la Coussaye JE, Houeto P, Sandouk P, Levillain P, Sassine A, Riou B. Pharmacokinetics of hydroxocobalamin in dogs. J Neurosurg Anesthesiol 1994; 6: 111-115.
11. Forsyth JC, Mueller PD, Becker CE, Osterloh J, Benowitz NL, Rumack BH, Hall AH. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol 1993; 31: 277-294.
12. Houeto P, Borron SW, Sandouk P, Imbert M, Levillain P, Baud FJ. Pharmacokinetics of hydroxocobalamin in smoke inhalation victims. J Toxicol Clin Toxicol 1996; 34: 397-404.
13. Riou B, Baud FJ, Astier A, Barriot P, Lecarpentier Y. I n vitro demonstration of the antidotal efficacy of hydroxocobalamin in cyanide poisoning. J Neurosurg Anesthesiol 1990; 2: 296-304.
14. Astier A, Baud F J. C omplexation of intracellular cyanide by hydroxocobalamin using a human cellular model. Hum Exp Toxicol 1996; 15: 19-25.
15. Mushett CW, Kelley KL, Boxer GE, Rickards JC. Antidotal efficacy of vitamin B 12a (hydroxocobalamin) in experimental cyanide poisoning. Proc Soc Exp Biol Med 1952; 81: 234-237.
16. Evans C L. Cobalt compounds as antidotes for hydrocyanic acid. B r J Pharmacol 1964; 23: 455-475.
17. Posner MA, Tobey RE, McElroy H. Hydroxocobalamin therapy of cyanide intoxication in guinea pigs. Anesthesiology 1976; 44: 157-160.
18. Rose CL, Worth RM, Chen KK. Hydroxo-cobalamine and acute cyanide poisoning in dogs. Life Sci 1965; 4: 1785-1789.
19. Borron SW, Stonerook M, Reid F. Efficacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs. Clin Toxicol 2006; 44: 5-15.
20. Hatch RC, Laflamme D P, Jain A V. Effects of various known and potential cyanide antagonists and a glutathione depletor on acute toxicity of cyanide in mice. Vet Hum Toxicol 1990; 32: 9-16.
21. Chan A, Balasubramanian M, Blackledge W, Mohammad OM, Alvarez L, Boss GR, Bigby TD. Cobinamide is superior to other treatments in a mouse model of cyanide poisoning. Clin Toxicol 2010; 48: 709-717.
22. Lawson-Smith P, Olsen N V, Hyldegaard O. H yperbaric oxygen therapy or hydroxycobalamin attenuates surges in brain interstitial lactate and glucose; and hyperbaric oxygen improves respiratory status in cyanide-intoxicated rats. Undersea Hyperb Med 2011; 38: 223-237.
23. Mengel K, Krmer W, Isert B, Friedberg KD. Thiosulphate and hydroxocobalamin prophylaxis in progressive cyanide poisoning in guinea-pigs. Toxicology 1989; 54: 335-342.
24. Brenner M, Mahon SB, Lee J, Kim J, Mukai D, Goodman S, et al. Comparison of cobinamide to hydroxocobalamin in reversing cyanide physiologic effects in rabbits using diffuse optical spectroscopy monitoring. J Biomed Opt 2010; 15: 017001.
25. Bebarta VS, Tanen DA, Lairet J, Dixon PS, Valtier S, Bush A. Hydroxocobalamin and sodium thiosulfate versus sodium nitrite and sodium thiosulfate in the treatment of acute cyanide toxicity in a swine (Sus scrofa) model. Ann Emerg Med 2010; 55: 345-351.
26. Jang DH, Nelson LS, Hoffman RS. Hydroxocobalamin and sodium thiosulfate versus sodium nitrite and sodium thiosulfate in acute cyanide toxicity. Ann Emerg Med 2010; 55: 582.
27. Bebarta VS, Tanen DA, Lairet J, Dixon PS. Hydroxocobalamin and sodium thiosulfate versus sodium nitrite and sodium thiosulfate in acute cyanide toxicity - in reply. Ann Emerg Med 2010; 55: 582-583.
28. Bebarta VS, Pitotti RL, Dixon PS, Valtier S, Esquivel L, Bush A, Little CM. Hydroxocobalamin and epinephrine both improve survival in a swine model of cyanide-induced cardiac arrest. Ann Emerg Med 2012. online early: doi: 10.1016/j.annemergmed.2012.02.002.
29. Bebarta VS, Pitotti RL, Dixon P, Lairet JR, Bush A, Tanen DA. Hydroxocobalamin versus sodium thiosulfate for the treatment of acute cyanide toxicity in a swine (Sus scrofa) model. Ann Emerg Med 2012; 59: 532-539.
30. Borron SW, Baud F J, Még arbane B, Bismuth C. H ydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med 2007; 25: 551-558.
31. Coentr.o L, Moura D. Acute cyanide poisoning among jewelry and textile industry workers. Am J Emerg Med 2011; 29: 78-81.
32. Payen C, Combe C, Le Meur C, Gaillard Y, Pulce C, Descotes J. Lethal acute poisoning with potassium ferrocyanide. Am J Emerg Med 2010; 28: 642.
33. Lutier F, D usoleil P, de Montgros J. Action de l'hydroxocobalamineàdose massive dans l'intoxication aigu. au cyanure. (A propos d'un cas). Arch Mal Prof 1971; 32: 683-686.
34. Tassan H, Joyon D, Richard T, Lamaison D, Guelon D, Barakeh S. [Potassium cyanide poisoning treated with hydroxocobalamin]. Ann Fr Anesth Réanim 1990; 9: 383-385.
35. Mannaioni G, Vannacci A, Marzocca C, Zorn AM, Peruzzi S, Moroni F. Acute cyanide intoxication treated with a combination of hydroxocobalamin, sodium nitrite, and sodium thiosulfate. J Toxicol Clin Toxicol 2002; 40: 181-183.
36. Hon KL, Cheung KL. Pink toes and red urine: what is this poison? Hong Kong Med J 2010; 16: 411-412.
37. Erdman A R. Reply to: "Is hydroxocobalamin safe and effective for smoke inhalation? searching for guidance in the haze" - in reply. Ann Emerg Med 2008; 51: 110-111.
38. Alarie Y. Toxicity of fire smoke. Crit Rev Toxicol 2002; 32: 259-289.
39. Wing KS, Cheung CY, Lung LF. Hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med 2008; 51: 108.
40. Due. as-Laita A, Burillo Putze G, Alonso JR, Bajo A, Climent B, Corral E, et al. Bases del manejo clinico de la intoxicacion por humo de incendios - Docohumo Madrid 2010. Med Intensiva 2010; 34: 609-619.
41. Breton D, Jouvet P, de BJ, Delacourt C, Hubert P. [Toxicity of fire smoke. Apropos of 2 pediatric cases]. Arch Fr Pediatr 1993; 50: 43-45.
42. Houeto P, Hoffman JR, Imbert M, Levillain P, Baud FJ. Relation of blood cyanide to plasma cyanocobalamin concentration after a fixed dose of hydroxocobalamin in cyanide poisoning. Lancet 1995; 346: 605-608.
43. Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med 2007; 49: 794-801.
44. D esola J. H ydroxycobalamin, hyperbaric oxygen and cyanide poisoning. Undersea Hyperb Med 2011; 38: 217-220.
45. Fortin JL, Giocanti JP, Ruttimann M, Kowalski JJ. Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade. Clin Toxicol 2006; 44: 37-44.
46. Fortin JL, Capellier G, Manzon C, Giocanti J, Gall O. Intraosseous administration of hydroxocobalamin in the acute treatment of cyanide poisoning. Burns 2009; 3. Suppl 1. S15 - S16.
47. Fortin JL, Judic-Peureux V, Desmettre T, Manzon C, Grimon D, Hostalek U, et al. Hydrogen cyanide poisoning in a prison environment: a case report. J Correct Health Care 2011; 17: 29-33.
48. Fortin J-L, Desmettre T, Manzon C, Judic-Peureux V, Peugeot- Mortier C, Giocanti J-P, et al. Cyanide poisoning and cardiac disorders: 16. cases. J Emerg Med 2010; 38: 467-476.
49. Roderique EJ, Gebre-Giorgis AA, Stewart DH, Feldman MJ, Pozez AL. Smoke inhalation injury in a pregnant patient: a literature review of the evidence and current best practices in the setting of a classic case. J Burn Care Res 2012; 33: 624-633.
50. Ballantyne B. C hemical terrorism. In: B allantyne B, Marrs T, Syversen T, eds. General and Applied Toxicology. 3rd ed. Chichester, UK: John Wiley & Sons; 2009; 2923-2946.
51. Bryson D. Acute industrial cyanide intoxication and its treatment. In: Ballantyne B, Marrs TC, eds. Clinical and Experimental Toxicology of Cyanides. Bristol, UK: Wright, IOP Publishing; 1987; 348-358.
52. Erdman AR. Is hydroxocobalamin safe and effective for inhalation? Searching for guidance in the haze. Ann Emerg Med 2007; 49: 814-816.
53. Sauer SW, Keim ME. Hydroxocobalamin: improved public health readiness for cyanide disasters. Ann Emerg Med 2001; 37: 635-641.
54. Keim ME. Terrorism involving cyanide: the prospect of improving preparedness in the prehospital setting. Prehosp Disaster Med 2006; 21. s56 - s60.
55. National Cancer Institute. Questions and answers about laetrile/amygdalin. [Online] 2010. Available at: http://www.cancer.gov/ cancertopics/pdq/cam/laetrile/patient/allpages#Section-20.
56. Akyildiz BN, Kurtoglu S, Kondolot M, Tunc A. Cyanide poisoning caused by ingestion of apricot seeds. Ann Trop Paediatr 2010; 30: 39-43.
57. Cigolini D, Ricci G, Zannoni M, Codogni R, De Luca M, Perfetti P, Rocca G. Hydroxocobalamin treatment of acute cyanide poisoning from apricot kernels. Emerg Med J 2011; 28: 804-805.
58. Zerbe NF, Wagner BK. Use of vitamin B12 in the treatment and prevention of nitroprusside-induced cyanide toxicity. Crit Care Med 1993; 21: 465-467.
59. Bismuth C, Baud FJ, Pontal PG. Hydroxocobalamin in chronic cyanide poisoning. J Toxicol Clin Exp 1988; 8: 35-38.
60. Beregi J P, Riou B, Lecarpentier Y. Effects of hydroxocobalamin on rat cardiac papillary muscle. Intensive Care Med 1991; 17: 175-177.
61. Riou B, Gérard J-L, La Rochelle CD, Bourdon R, Berdeaux A, Giudicelli J-F. Hemodynamic effects of hydroxocobalamin in conscious dogs. Anesthesiology 1991; 74: 552-558.
62. Riou B, Berdeaux A, Pussard E, Giudicelli JF. Comparison of the hemodynamic effects of hydroxocobalamin and cobalt edetate at equipotent cyanide antidotal doses in conscious dogs. Intensive Care Med 1993; 19: 26-32.
63. Pery-Man N, Houeto P, Coirault C, Suard I, Perennec J, Riou B, Lecarpentier Y. Hydroxocobalamin vs cobalt toxicity on rat cardiac and diaphragmatic muscles. Intensive Care Med 1996; 22: 108-115.
64. Curry SC, Connor DA, Raschke RA. Effect of the cyanide antidote hydroxocobalamin on commonly ordered serum chemistry studies. Ann Emerg Med 1994; 24: 65-67.
65. Hudson M, Cashin BV, Matlock AG, Kang C, Wills BK. A man with purple urine. Clin Toxicol 2012; 50: 77.
66. Torremade Barreda J, S errallach Orejas M, Valles-Ortega J, Franco Miranda E. Treatment with hydroxocobalamin for cyanide poisoning: a rare cause of pseudohematuria. Actas Urol Esp 2010; 34: 124-126.
67. Sutter M, Tereshchenko N, Rafii R, Daubert GP. Hemodialysis complications of hydroxocobalamin: a case report. J Med Toxicol 2010; 6: 165-167.
68. Uhl W, Nolting A, Golor G, Rost K L, Kovar A. Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. Clin Toxicol 2006; 44: 17-28.
69. Hvding G. A naphylactic reaction after injection of vitamin B 12. Br Med J 1968; 3: 102.
70. Dally S, Gaultier M. [ Anaphylactic shock caused by hydroxocobalamin]. Nouv Presse Med 1976; 5: 1917.
71. Uqwu C N, Q ibbins F J. A naphylactic reaction to vitamin B 1. appearing after several years of therapy. Age Ageing 1981; 10: 196-97.
72. James J, Warin R P. Sensitivity to cyanocobalamin and hydroxocobalamin. Br Med J 1971; 2: 262.
73. Pevny I, Hartmann A, Metz J. [ Vitamin B 12-(cyanocobalamin)- allergy]. Hautarzt 1977; 28: 600-603.
74. Vidal C, Lorenzo A. Anaphylactoid reaction to hydroxycobalamin with tolerance of cyanocobalamin. Postgrad Med J 1998; 74: 702.
75. Bilwani F, A dil S N, Sheikh U, Humera A, Khurshid M. A naphylactic reaction after intramuscular injection of cyanocobalamin (vitamin B12): a case report. J Pak Med Assoc 2005; 55: 217-219.
76. Moloney FJ, Hughes R, O'Shea D, Kirby B. Type Iimmediate hypersensitivity reaction to cyanocobalamin but not hydroxycobalamin. Clin Exp Dermatol 2008; 33: 412-414.
77. Branco-Ferreira M, Clode MH, Pereira-Barbosa MA, Palma-Carlos AG. Anaphylactic reaction to hydroxycobalamin. Allergy 1997; 52: 118-119.
78. Tordjman R, Genereau T, Guinnepain M-T, Weyer A, Lortholary O, Royer I, et al. Reintroduction of vitamin B 1. in 2 patients with prior B 12 -induced anaphylaxis. Eur J Haematol 1998; 60: 269-270.
79. Djuric V, Bogic M, Popadic A P, Spiric V T, Raskovic S. Anaphylactic reaction to hydroxycobalamin with tolerance to cyanocobalamin. Ann Allergy Asthma Immunol 2012; 108: 207-208.
80. Gourlain H, Caliez C, Laforge M, Buneaux F, Levillain P. Study of the mechanisms involved in hydroxocobalamin interference with determination of some biochemical parameters. Ann Biol Clin 1994; 52: 121-124.
81. Vest P, Renaudeau C, Tellal S, Ragot C, Renard C. [ Interference of hydroxocobalamine treatment on commun biochemical determinations]. Ann Biol Clin 2002; 60: 57-64.
82. Lee J, Mukai D, Kreuter K, Mahon S, Tromberg B, Brenner M. Potential interference by hydroxocobalamin on cooximetry hemoglobin measurements during cyanide and smoke inhalation treatments. Ann Emerg Med 2007; 49: 802-805.
83. Carlsson CJ, Hansen HE, Hilsted L, Malm J,. dum L, Szecsi PB. An evaluation of the interference of hydroxycobalamin with chemistry and co-oximetry tests on nine commonly used instruments. Scand J Clin Lab Invest 2011; 71: 378-386.